AIM
Axiom Investment Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $618K | Sell |
7,195
-3,819
| -35% | -$328K | 1.61% | 14 |
|
|
2022
Q3 | $679K | Sell |
11,014
-2,249
| -17% | -$139K | 1.36% | 16 |
|
|
2022
Q2 | $819K | Sell |
13,263
-45,445
| -77% | -$2.81M | 2.35% | 10 |
|
|
2022
Q1 | $3.49M | Sell |
58,708
-4,063
| -6% | -$242K | 7.59% | 1 |
|
|
2021
Q4 | $4.56M | Sell |
62,771
-9,906
| -14% | -$719K | 4.42% | 5 |
|
|
2021
Q3 | $5.08M | Buy |
72,677
+2,337
| +3% | +$163K | 5.1% | 3 |
|
|
2021
Q2 | $4.84M | Buy |
70,340
+17,207
| +32% | +$1.18M | 3.76% | 6 |
|
|
2021
Q1 | $3.44M | Buy |
53,133
+52,611
| +10,079% | +$3.4M | 2.8% | 7 |
|
|
2020
Q4 | $1.21K | Buy |
+522
| New | +$1.21K | 1.1% | 25 |
|
|
2020
Q2 | – | Sell |
-3,142
| Closed | -$236K | – | 131 |
|
|
2020
Q1 | $236K | Buy |
+3,142
| New | +$236K | 0.42% | 68 |
|
|
2019
Q4 | – | Sell |
-3,292
| Closed | -$208K | – | 171 |
|
|
2019
Q3 | $208K | Sell |
3,292
-3,959
| -55% | -$250K | 0.16% | 154 |
|
|
2019
Q2 | $491K | Sell |
7,251
-586
| -7% | -$39.7K | 0.09% | 222 |
|
|
2019
Q1 | $510K | Buy |
7,837
+1,507
| +24% | +$98.1K | 0.1% | 216 |
|
|
2018
Q4 | $396K | Buy |
+6,330
| New | +$396K | 0.08% | 215 |
|